Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InvestorWire is a multifaceted financial news and publishing company that provides press release distribution, wire services, and investor relations solutions. As a key brand within the InvestorBrandNetwork (IBN), it specializes in enhancing corporate exposure for both public and private companies across diverse sectors, including life sciences, technology, and consumer goods. The company utilizes a massive distribution network of over 5,000 syndication outlets to ensure broad visibility for its clients' corporate news and regulatory filings. In addition to traditional wire services, InvestorWire offers social media integration and digital brand awareness tools to help companies connect with a global audience of investors and consumers. Its services are designed to bridge the communication gap between companies and the investment community. While not a biotechnology company itself, InvestorWire is a prominent service provider within the healthcare sector, frequently disseminating news for emerging biotech firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InvestorWire.